COVID-19 vaccination program interim playbook for COVID-19 vaccination program : jurisdiction operations

Immunization with a safe and effective COVID-19 vaccine is a critical component of the United States strategy to reduce COVID-19-related illnesses, hospitalizations, and deaths and to help restore societal functioning. The goal of the U.S. government is to have enough COVID-19 vaccine for all people in the United States who wish to be vaccinated. Early in the COVID-19 Vaccination Program, there may be a limited supply of COVID-19 vaccine, and vaccination efforts may focus on those critical to the response, providing direct care, and maintaining societal function, as well as those at highest risk for developing severe illness from COVID-19. This document serves as an interim playbook for state, territorial (including the US-affiliated Pacific Islands [USAPI] of American Samoa, the Commonwealth of the Northern Mariana Islands, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau), and local public health programs and their partners on how to plan and operationalize a vaccination response to COVID-19 within their jurisdictions. The document\u2019s sections cover specific areas of COVID-19 vaccination program planning and implementation and provide key guidance documents and links to resources to assist those efforts. Many, but not all, of the COVID-19 Vaccination Program activities described may overlap with routine activities; routine immunization and pandemic influenza program activities can serve as a foundation for COVID-19 vaccination planning. Centers for Disease Control and Prevention (CDC) Immunization and Vaccines for Children Cooperative Agreement funding recipients (i.e., \u201cawardees\u201d) should use this document to develop their COVID-19 vaccination plans. Within their vaccination plans, awardees must address all requirements outlined in the playbook and clearly describe their responsibility for ensuring activities are implemented. Awardees should submit their plans to their CDC project officer by October 16, 2020. Information in this interim playbook will be updated as new information (e.g., recommendations for pregnant women or pediatric populations) becomes available.COVID19_VACCINATION_PROGRAM_PLAYBOOK.PDFExecutive Summary -- Section 1: Public Health Preparedness Planning -- Section 2: COVID-19 Organizational Structure and Partner Involvement -- Section 3: Phased Approach to COVID-19 Vaccination -- Section 4: Critical Populations -- Section 5: COVID-19 Vaccination Provider Recruitment and Enrollment -- Section 6: Understanding a Jurisdiction\u2019s COVID-19 Vaccine Administration Capacity -- Section 7: COVID-19 Vaccine Allocation, Ordering, Distribution, and Inventory Management -- Section 8: COVID-19 Vaccine Storage and Handling -- Section 9: COVID-19 Vaccine Administration Documentation and Reporting -- Section 10: COVID-19 Vaccination Second-Dose Reminders -- Section 11: COVID-19 Requirements for Immunization Information Systems or Other External Systems -- Section 12: COVID-19 Vaccination Program Communication -- Section 13: Regulatory Considerations for COVID-19 Vaccination -- Section 14: COVID-19 Vaccine Safety Monitoring -- Section 15: COVID-19 Vaccination Program Monitoring -- Appendix A: COVID-19 Vaccination Planning Assumptions for Jurisdictions (revised 9/15/2020) Appendix B: COVID-19 Vaccination Scenarios for Jurisdictional Planning\u2014Phase 1, Q4 2020 (updated 9/25/2020) -- Appendix C: Phase 1 Population Group Worksheet Example -- Appendix D: CDC IIS Data Requirements for COVID-19 Vaccine Monitoring -- Appendix E: Countermeasures Injury Compensation Program -- Appendix F: Liability Immunity for Covered Persons.2020https://media.defense.gov/2020/Sep/16/2002498510/-1/-1/1/COVID19_VACCINATION_PROGRAM_PLAYBOOK.PDF75 numbered pages865